First-line pembrolizumab plus chemotherapy for patients with advanced squamous NSCLC: 3-year follow-up from KEYNOTE-407

MERMAID-2: Phase 3 study of durvalumab in patients with resected stage MRD II-III NSCLC

Cemiplimab plus ipilimumab for advanced NSCLC

Highlights from AORTIC Cancer Genomics Conference 2021

The Conquering Cancer Campaign

Managing the treatment of NSCLC patients during the COVID-19 pandemic (FR)

Managing the treatment of NSCLC patients during the COVID-19 pandemic (DE)

Managing the treatment of NSCLC patients during the COVID-19 pandemic (IT)

Managing the treatment of NSCLC patients during the COVID-19 pandemic (ES)

Cabozantinib most effective treatment for metastatic papillary kidney cancer

Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC

Nurse's perspective on PARP inhibitors and personalised medicine in prostate cancer